Table:
begin	end	state
1	31	cytoplasmic
32	50	transmembrane
51	63	non-cytoplasmic
64	82	transmembrane
83	96	cytoplasmic
97	116	transmembrane
117	121	non-cytoplasmic
122	144	transmembrane
145	155	cytoplasmic
156	179	transmembrane
180	189	non-cytoplasmic
190	211	transmembrane
212	258	cytoplasmic
259	281	transmembrane
282	295	non-cytoplasmic
296	315	transmembrane
316	324	cytoplasmic
325	341	transmembrane
342	346	non-cytoplasmic
347	368	transmembrane
369	378	cytoplasmic
379	402	transmembrane
403	413	non-cytoplasmic
414	433	transmembrane
434	455	cytoplasmic

Input:
>PP_4758 FitnessBrowser__Putida:PP_4758
MGDPQVNDTLAPSARHEGDALASAVAKVKRHVLPLFVIMFIVNYLDRVNIGFVRPHLESD
LGISAAAYGFGAGLFFIGYALFEVPSNMLLQKVGARLWLTRIMFTWGLVATAMAFVQNET
QFYVLRFLLGVAEAGFFPGVIYYFTRWLPAAERGKAIAIFLSGSALASLISGPLAGALMQ
IQGLGLHGWQWMLFIEGMASVALCFFVFFWLDSKPQDAKWLSKAEQDALVATIDREQQAR
EAIGAVRPSAWNLLKDRQIVLFCLIYFCIQLTIYAATFWLPSIIKRMGDLSDMQVGFFNS
IPWLISILAMYAFAAGSARWKFQQAWVAGALLVAATGMFMSTTGGPVFAFVAVCFAAIGF
KSASSLFWPIPQGYLDARIAAAVIALINSVGNLGGFVAPTTFGLLEQQTGSIQGGLYGLA
VTSVLAAIAIFFVRTRPKGAPSDDLKAPSALGQTH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server